Medicare Part D Plans To Control Opioid Access With ‘Lock In’ Program
Addiction prevention legislation empowers Medicare drug plans to restrict prescriber, pharmacy access to opioids for ‘at risk’ beneficiaries.
You may also be interested in...
Comprehensive opioid addiction legislation is considered by House-Senate conference committee on July 6.
CMS notes some success in reducing the number of beneficiaries overusing opioids but proposes additional action for plans to manage access.
White House sends out short press release as FDA is conducting an unrelated briefing to announce the user fee bill was enacted, surprising stakeholders and generating political questions.